Skip to main content

Diabetes Drug News

Diabetes Drugs are responsible for helping to decrease blood sugar levels so that you can try to stay in a healthier range and help avoid serious complications.

Metformin     Insulin     SGLT-2     GLP-1     DPP-4     Combo drugs     Sulfonylureas     TZDs

With unemployment rising, Lilly’s Insulin Value Program limits insulin prescription costs to $35 a month for people who are uninsured or who have commercial insurance
Rybelsus, a GLP-1 agonist pill already approved in the US, received positive feedback from the European Medicines Agency (EMA) in January and was just approved on...
Make sure that you have, and are able to access, insulin during the coronavirus pandemic. Here are tips to stay prepared
Early trial results found that SGLT-2 inhibitor Farxiga is highly effective for preventing and treating kidney disease in people with or without type 2 diabetes
By Jimmy McDermott Lilly does not expect any medication shortages during the coronavirus pandemic, and reminds people with diabetes about cost saving programs for...
Dr. Fran Kaufman, a pediatric endocrinologist, shares 9 key steps to get the most out of your virtual visit
The program is predicted to save older Americans hundreds of dollars per year
Expert advice on preparing for the coronavirus: prescription refills, sick day kits, and general precautions. Updated 3/17/20
Under the rule, people using prescription discount coupons would have to spend more money in order to meet their deductibles
Trulicity can now be prescribed to reduce the risk of stroke and heart attack in adults with type 2 diabetes and with heart disease or those who at risk for heart disease
Indiana is the only state that requires a prescription for human insulin. Pending the Governor's signature, this is soon to change.
Eli Lilly to donate 200,000 insulin pens and provide $2 million for diabetes education to 200 free clinics across the United States by 2022
Every February the Spare a Rose, Save a Child campaign raises funds to provide insulin and other diabetes supplies to children with type 1 in under-resourced countries...
A new pill combines Jardiance, Tradjenta, and metformin to help people with type 2 diabetes manage blood glucose levels more easily, and in many different ways
Ozempic, a once weekly injectable GLP-1 agonist drug, is now approved to reduce the risk of heart attack and stroke. Rybelsus (a pill version of Ozempic) is confirmed to...
New updates include the recommendation of GLP-1 agonists and SGLT-2 inhibitors for heart and kidney protection, earlier combination therapy in type 2 diabetes, GLP-1...
FDA approval the fast-acting insulin for children means that children will have more flexibility in their mealtime insulin dosing
Read on to learn about the research around GLP-1, SGLT-2, and combination therapy use in type 1 diabetes. Dr. Paresh Dandona is a Distinguished Professor and Chief of...
New guidelines from ADA and EASD focus on GLP-1 agonists and SGLT-2 inhibitors to improve heart and kidney health
Farxiga’s heart health benefits were the same in people with and without diabetes, as well as across a spectrum of baseline A1C levels

Pages